These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 998139)

  • 41. Porcine factor VIII:C prepared by affinity interaction with von Willebrand factor and heterologous antibodies: sodium dodecyl sulfate polyacrylamide gel analysis.
    Knutson GJ; Fass DN
    Blood; 1982 Mar; 59(3):615-24. PubMed ID: 6800420
    [No Abstract]   [Full Text] [Related]  

  • 42. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.
    Fulcher CA; Zimmerman TS
    Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1648-52. PubMed ID: 6803246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of large-scale fractionation methods. VI. An improved method for preparation of antihemophilic factor.
    Wickerhauser M; Mercer JE; Eckenrode JW
    Vox Sang; 1978; 35(1-2):18-31. PubMed ID: 664566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.
    Andersson LO; Forsman N; Huang K; Larsen K; Lundin A; Pavlu B; Sandberg H; Sewerin K; Smart J
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2979-83. PubMed ID: 3085106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolation, subunit structure, and proteolytic modification of bovine factor VIII.
    Legaz ME; Weinstein MJ; Heldebrant CM; Davie EW
    Ann N Y Acad Sci; 1975 Jan; 240():43-61. PubMed ID: 122888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [New preparation of antihemophilic globulin (factor VIII) obtained by means of cryoprecipitation and the use of dextran].
    Lopaciuk S; Naleczyńska A; Daszyński J; Klenowska Z
    Acta Haematol Pol; 1971; 2(2):103-8. PubMed ID: 5161830
    [No Abstract]   [Full Text] [Related]  

  • 47. Isolation and characterization of different activated forms of factor VIII, the human antihemophilic A factor.
    Bihoreau N; Sauger A; Yon JM; Van de Pol H
    Eur J Biochem; 1989 Oct; 185(1):111-8. PubMed ID: 2509202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biologic and chemical characterization of HLA antigens in human serum.
    Allison JP; Pellegrino MA; Ferrone S; Callahan GN; Reisfeld RA
    J Immunol; 1977 Mar; 118(3):1004-9. PubMed ID: 191523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Electrophoretic patterns of differently prepared fibrinogen subunits in sodium dodecyl sulfate containing polyacrylamide gels].
    Lober M; Krantz S
    Acta Biol Med Ger; 1977; 36(10):1363-7. PubMed ID: 567415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dispersity of human factor VIII--Von Willebrand factor.
    van Mourik JA; Bolhuis PA
    Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
    [No Abstract]   [Full Text] [Related]  

  • 51. Multiple molecular forms of endothelial cell factor VIII related antigen.
    Nachman RL; Jaffe EA; Ferris B
    Biochim Biophys Acta; 1981 Feb; 667(2):361-9. PubMed ID: 6783119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dissociation of factor VIII by reducing agents, high salt concentration and affinity chromatography.
    Peake IR; Bloom AL
    Thromb Haemost; 1976 Feb; 35(1):191-201. PubMed ID: 989186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation of antihemophilic factor from indated plasma.
    Wickerhauser M
    Transfusion; 1976; 16(4):345-50. PubMed ID: 951729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified glycine precipitation technique for the preparation of factor VIII concentrate of high purity and high stability.
    Brodniewicz-Proba T; Beauregard D
    Vox Sang; 1987; 52(1-2):10-4. PubMed ID: 3111087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isolation of human antibodies to factor VIII.
    Lavergne JM; Meyer D; Koutts J; Larrieu MJ
    Br J Haematol; 1978 Dec; 40(4):631-41. PubMed ID: 365219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyanogen bromide and tryptic fragments of normal and haemophilic factor VIII.
    Holmberg L; Jeppsson JO; Nilsson IM; Stenflo J
    Thromb Res; 1975 Jun; 6(6):523-32. PubMed ID: 1154327
    [No Abstract]   [Full Text] [Related]  

  • 57. Variable degradation of factor VIII-related protein in lyophilised concentrates of antihaemophilic factor (AHF).
    Jakab T; Pflugshaupt R; Furlan M; Beck EA
    Vox Sang; 1978; 35(1-2):36-40. PubMed ID: 664567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitate.
    Horowitz B; Lippin A; Chang MY; Shulman RW; Vandersande J; Stryker MH; Woods KR
    Transfusion; 1984; 24(4):357-62. PubMed ID: 6431661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on the purification of antihemophilic factor (factor 8. I. Precipitation of antihemophilic factor by concanavalin A.
    Kass L; Ratnoff OD; Leon MA
    J Clin Invest; 1969 Feb; 48(2):351-8. PubMed ID: 5812636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation and partial characterization of human factor V.
    Bolhuis PA; Hakvoort TB; Breederveld K; Mochtar IA; ten Cate JW
    Biochim Biophys Acta; 1979 May; 578(1):23-30. PubMed ID: 454668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.